Last reviewed · How we verify

Placebo for varenicline

Nathan Kline Institute for Psychiatric Research · FDA-approved active Small molecule

A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect.

A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect. Used for Control arm in clinical trials for smoking cessation (varenicline comparator).

At a glance

Generic namePlacebo for varenicline
Also known asplacebo for Champix(R) / Chantix(R), Placebo
SponsorNathan Kline Institute for Psychiatric Research
ModalitySmall molecule
Therapeutic areaPsychiatry / Addiction Medicine
PhaseFDA-approved

Mechanism of action

Placebo is an inert substance used as a control in clinical trials to measure the effect of an active drug (in this case, varenicline) against baseline or non-specific therapeutic effects. Any observed benefit from placebo is attributed to psychological factors, natural disease progression, or regression to the mean rather than direct molecular action.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: